Skip to main content
Erschienen in: Obesity Surgery 7/2017

15.05.2017 | New Concept

Surgical Management of Obesity Among People with Schizophrenia and Bipolar Disorder: a Systematic Review of Outcomes and Recommendations for Future Research

verfasst von: Youssef Kouidrat, Ali Amad, Brendon Stubbs, Suzan Moore, Fiona Gaughran

Erschienen in: Obesity Surgery | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

People with schizophrenia or bipolar disorder (BD) exhibit very high levels of obesity. Little is known about the potential benefits/risks of obesity surgery. We conducted a narrative review to summarize the available knowledge on bariatric surgery in people with schizophrenia or BD.

Methods

A systematic search was conducted of major electronic databases from inception to October 2016 for studies investigating bariatric surgery among people with schizophrenia or BD. Data were presented in a narrative synthesis and future research strategies proposed.

Results

The electronic database searches identified 44 records. Eight studies (BD, n = 265; schizophrenia: n = 14) were included with a mean study length of 15.7 months (12–24). Seven found that bariatric surgery resulted in weight loss in those with psychiatric disorders with an excess weight loss ranging −31 to −70%. Six studies found that weight loss from bariatric surgery was similar in people with schizophrenia or BD versus controls. However, most of the studies limited their outcomes to only weight loss and did not measure whether obesity surgery affected the status and treatment of psychiatric symptoms. Although few adverse events were reported among patients with BD, data from two studies demonstrated no significant deterioration of psychiatric symptoms post-surgery in people with schizophrenia.

Conclusions

Growing evidence suggests that bariatric surgery may improve short-term weight status among people with BD. However, given the paucity of studies for schizophrenia, and the lack of information on medium-to long-term results, future large-scale high-quality studies are required.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Stubbs B, Vancampfort D, Solmi M, et al. How common is bipolar disorder in general primary care attendees? A systematic review and meta-analysis investigating prevalence determined according to structured clinical assessments. Aust N Z J Psychiatry. 2016;50:631–9.CrossRefPubMed Stubbs B, Vancampfort D, Solmi M, et al. How common is bipolar disorder in general primary care attendees? A systematic review and meta-analysis investigating prevalence determined according to structured clinical assessments. Aust N Z J Psychiatry. 2016;50:631–9.CrossRefPubMed
4.
Zurück zum Zitat Vancampfort D, Stubbs B, Mitchell AJ, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14:339–47.CrossRefPubMedPubMedCentral Vancampfort D, Stubbs B, Mitchell AJ, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14:339–47.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 2015. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 2015.
6.
Zurück zum Zitat Kouidrat Y, Amad A, Arai M, et al. Advanced glycation end products and schizophrenia: a systematic review. J Psychiatr Res. 2015;66–67:112–7. Kouidrat Y, Amad A, Arai M, et al. Advanced glycation end products and schizophrenia: a systematic review. J Psychiatr Res. 2015;66–67:112–7.
7.
Zurück zum Zitat Kouidrat Y, Amad A, Lalau JD, et al. Eating disorders in schizophrenia: implications for research and management. Schizophr Res Treatment. 2014; 791573. doi:10.1155/2014/791573. Kouidrat Y, Amad A, Lalau JD, et al. Eating disorders in schizophrenia: implications for research and management. Schizophr Res Treatment. 2014; 791573. doi:10.​1155/​2014/​791573.
8.
Zurück zum Zitat Caemmerer J, Correll CU, Maayan L. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials. Schizophr Res. 2012;140:159–68.CrossRefPubMed Caemmerer J, Correll CU, Maayan L. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials. Schizophr Res. 2012;140:159–68.CrossRefPubMed
9.
Zurück zum Zitat Firth J, Cotter J, Elliott R, et al. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med. 2015;45:1343–61.CrossRefPubMed Firth J, Cotter J, Elliott R, et al. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med. 2015;45:1343–61.CrossRefPubMed
10.
Zurück zum Zitat Kouidrat Y, Amad A, De Hert M. Emerging drugs and indications for cardio-metabolic disorders in people with severe mental illness. Curr Pharm Des. 2015;21:3317–24.CrossRefPubMed Kouidrat Y, Amad A, De Hert M. Emerging drugs and indications for cardio-metabolic disorders in people with severe mental illness. Curr Pharm Des. 2015;21:3317–24.CrossRefPubMed
11.
Zurück zum Zitat De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26:1659–96.CrossRefPubMed De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26:1659–96.CrossRefPubMed
12.
Zurück zum Zitat Sarwer DB, Cohn NI, Gibbons LM, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg. 2004;14:1148–56.CrossRefPubMed Sarwer DB, Cohn NI, Gibbons LM, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg. 2004;14:1148–56.CrossRefPubMed
13.
Zurück zum Zitat Mühlhans B, Horbach T, de Zwaan M. Psychiatric disorders in bariatric surgery candidates: a review of the literature and results of a German prebariatric surgery sample. Gen Hosp Psychiatry. 2009;31:414–21.CrossRefPubMed Mühlhans B, Horbach T, de Zwaan M. Psychiatric disorders in bariatric surgery candidates: a review of the literature and results of a German prebariatric surgery sample. Gen Hosp Psychiatry. 2009;31:414–21.CrossRefPubMed
14.
Zurück zum Zitat Mitchell JE, Selzer F, Kalarchian MA, et al. Psychopathology before surgery in the longitudinal assessment of bariatric surgery-3 (LABS-3) psychosocial study. Surg Obes Relat Dis. 2012;8:533–41.CrossRefPubMedPubMedCentral Mitchell JE, Selzer F, Kalarchian MA, et al. Psychopathology before surgery in the longitudinal assessment of bariatric surgery-3 (LABS-3) psychosocial study. Surg Obes Relat Dis. 2012;8:533–41.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Malik S, Mitchell JE, Engel S, et al. Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews. Compr Psychiatry. 2014;55:248–59.CrossRefPubMed Malik S, Mitchell JE, Engel S, et al. Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews. Compr Psychiatry. 2014;55:248–59.CrossRefPubMed
16.
Zurück zum Zitat Booth H, Khan O, Prevost AT, et al. Impact of bariatric surgery on clinical depression. Interrupted time series study with matched controls. J Affect Disord. 2015;174:644–9.CrossRefPubMed Booth H, Khan O, Prevost AT, et al. Impact of bariatric surgery on clinical depression. Interrupted time series study with matched controls. J Affect Disord. 2015;174:644–9.CrossRefPubMed
17.
Zurück zum Zitat Dawes AJ, Maggard-Gibbons M, Maher AR, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA. 2016;315:150–63.CrossRefPubMed Dawes AJ, Maggard-Gibbons M, Maher AR, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA. 2016;315:150–63.CrossRefPubMed
18.
Zurück zum Zitat Duarte-Guerra LS, Coêlho BM, Santo MA, et al. Psychiatric disorders among obese patients seeking bariatric surgery: results of structured clinical interviews. Obes Surg. 2015;25:830–7.CrossRefPubMed Duarte-Guerra LS, Coêlho BM, Santo MA, et al. Psychiatric disorders among obese patients seeking bariatric surgery: results of structured clinical interviews. Obes Surg. 2015;25:830–7.CrossRefPubMed
19.
Zurück zum Zitat Grothe KB, Mundi MS, Himes SM, et al. Bipolar disorder symptoms in patients seeking bariatric surgery. Obes Surg. 2014;24:1909–14.CrossRefPubMed Grothe KB, Mundi MS, Himes SM, et al. Bipolar disorder symptoms in patients seeking bariatric surgery. Obes Surg. 2014;24:1909–14.CrossRefPubMed
20.
Zurück zum Zitat Roerig JL, Steffen K. Psychopharmacology and bariatric surgery. Eur Eat Disord Rev. 2015;23:463–9.CrossRefPubMed Roerig JL, Steffen K. Psychopharmacology and bariatric surgery. Eur Eat Disord Rev. 2015;23:463–9.CrossRefPubMed
22.
Zurück zum Zitat Hamoui N, Kingsbury S, Anthone GJ, et al. Surgical treatment of morbid obesity in schizophrenic patients. Obes Surg. 2004;14:349–52.CrossRefPubMed Hamoui N, Kingsbury S, Anthone GJ, et al. Surgical treatment of morbid obesity in schizophrenic patients. Obes Surg. 2004;14:349–52.CrossRefPubMed
23.
Zurück zum Zitat Steinmann WC, Suttmoeller K, Chitima-Matsiga R, et al. Bariatric surgery: 1-year weight loss outcomes in patients with bipolar and other psychiatric disorders. Obes Surg. 2011;21:1323–9.CrossRefPubMed Steinmann WC, Suttmoeller K, Chitima-Matsiga R, et al. Bariatric surgery: 1-year weight loss outcomes in patients with bipolar and other psychiatric disorders. Obes Surg. 2011;21:1323–9.CrossRefPubMed
24.
Zurück zum Zitat Ahmed AT, Warton EM, Schaefer CA, et al. The effect of bariatric surgery on psychiatric course among patients with bipolar disorder. Bipolar Disord. 2013;15:753–63.CrossRefPubMedPubMedCentral Ahmed AT, Warton EM, Schaefer CA, et al. The effect of bariatric surgery on psychiatric course among patients with bipolar disorder. Bipolar Disord. 2013;15:753–63.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Hayden MJ, Murphy KD, Brown WA, et al. Axis I disorders in adjustable gastric band patients: the relationship between psychopathology and weight loss. Obes Surg. 2014;24:1469–75.CrossRefPubMed Hayden MJ, Murphy KD, Brown WA, et al. Axis I disorders in adjustable gastric band patients: the relationship between psychopathology and weight loss. Obes Surg. 2014;24:1469–75.CrossRefPubMed
26.
Zurück zum Zitat Shelby SR, Labott S, Stout RA. Bariatric surgery: a viable treatment option for patients with severe mental illness. Surg Obes Relat Dis 2015. Shelby SR, Labott S, Stout RA. Bariatric surgery: a viable treatment option for patients with severe mental illness. Surg Obes Relat Dis 2015.
27.
Zurück zum Zitat Fuchs HF, Laughter V, Harnsberger CR, et al. Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success. Surg Endosc. 2016;30:251–8.CrossRefPubMed Fuchs HF, Laughter V, Harnsberger CR, et al. Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success. Surg Endosc. 2016;30:251–8.CrossRefPubMed
28.
Zurück zum Zitat Thomson L, Sheehan KA, Meaney C, et al. Prospective study of psychiatric illness as a predictor of weight loss and health related quality of life one year after bariatric surgery. J Psychosom Res. 2016;86:7–12.CrossRefPubMed Thomson L, Sheehan KA, Meaney C, et al. Prospective study of psychiatric illness as a predictor of weight loss and health related quality of life one year after bariatric surgery. J Psychosom Res. 2016;86:7–12.CrossRefPubMed
30.
Zurück zum Zitat McIntyre RS, Fallu A, Konarski JZ. Measurable outcomes in psychiatric disorders: remission as a marker of wellness. Clin Ther. 2006;28:1882–91.CrossRefPubMed McIntyre RS, Fallu A, Konarski JZ. Measurable outcomes in psychiatric disorders: remission as a marker of wellness. Clin Ther. 2006;28:1882–91.CrossRefPubMed
31.
Zurück zum Zitat Andreasen NC, Carpenter WT, Kane JM, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–9.CrossRefPubMed Andreasen NC, Carpenter WT, Kane JM, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–9.CrossRefPubMed
32.
Zurück zum Zitat Llorca P-M, Lançon C, Lancrenon S, et al. The “Functional Remission of General Schizophrenia” (FROGS) scale: development and validation of a new questionnaire. Schizophr Res. 2009;113:218–25.CrossRefPubMed Llorca P-M, Lançon C, Lancrenon S, et al. The “Functional Remission of General Schizophrenia” (FROGS) scale: development and validation of a new questionnaire. Schizophr Res. 2009;113:218–25.CrossRefPubMed
33.
Zurück zum Zitat Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5.CrossRefPubMedPubMedCentral Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Fabricatore AN, Crerand CE, Wadden TA, et al. How do mental health professionals evaluate candidates for bariatric surgery? Survey results. Obes Surg. 2006;16:567–73.CrossRefPubMed Fabricatore AN, Crerand CE, Wadden TA, et al. How do mental health professionals evaluate candidates for bariatric surgery? Survey results. Obes Surg. 2006;16:567–73.CrossRefPubMed
36.
Zurück zum Zitat Sogg S, Lauretti J, West-Smith L. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis. 2016;12:731–49.CrossRefPubMed Sogg S, Lauretti J, West-Smith L. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis. 2016;12:731–49.CrossRefPubMed
37.
Zurück zum Zitat Maddi SR, Fox SR, Khoshaba DM, et al. Reduction in psychopathology following bariatric surgery for morbid obesity. Obes Surg. 2001;11:680–5.CrossRefPubMed Maddi SR, Fox SR, Khoshaba DM, et al. Reduction in psychopathology following bariatric surgery for morbid obesity. Obes Surg. 2001;11:680–5.CrossRefPubMed
38.
Zurück zum Zitat Burgmer R, Legenbauer T, Müller A, et al. Psychological outcome 4 years after restrictive bariatric surgery. Obes Surg. 2014;24:1670–8.CrossRefPubMed Burgmer R, Legenbauer T, Müller A, et al. Psychological outcome 4 years after restrictive bariatric surgery. Obes Surg. 2014;24:1670–8.CrossRefPubMed
39.
Zurück zum Zitat Shen S-C, Lin H-Y, Huang C-K, et al. Adherence to psychiatric follow-up predicts 1-year BMI loss in gastric bypass surgery patients. Obes Surg. 2016;26:810–5.CrossRefPubMed Shen S-C, Lin H-Y, Huang C-K, et al. Adherence to psychiatric follow-up predicts 1-year BMI loss in gastric bypass surgery patients. Obes Surg. 2016;26:810–5.CrossRefPubMed
40.
Zurück zum Zitat Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11:41–50.CrossRefPubMed Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11:41–50.CrossRefPubMed
41.
Zurück zum Zitat Hamad GG, Helsel JC, Perel JM, et al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry. 2012;169:256–63.CrossRefPubMedPubMedCentral Hamad GG, Helsel JC, Perel JM, et al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry. 2012;169:256–63.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Cunningham JL, Merrell CC, Sarr M, et al. Investigation of antidepressant medication usage after bariatric surgery. Obes Surg. 2012;22:530–5.CrossRefPubMed Cunningham JL, Merrell CC, Sarr M, et al. Investigation of antidepressant medication usage after bariatric surgery. Obes Surg. 2012;22:530–5.CrossRefPubMed
43.
Zurück zum Zitat Alam A, Raouf S, Recio FO. Lithium toxicity following vertical sleeve gastrectomy: a case report. Clin Psychopharmacol Neurosci. 2016;14:318–20.CrossRefPubMedPubMedCentral Alam A, Raouf S, Recio FO. Lithium toxicity following vertical sleeve gastrectomy: a case report. Clin Psychopharmacol Neurosci. 2016;14:318–20.CrossRefPubMedPubMedCentral
44.
45.
Zurück zum Zitat Steffen KJ, Engel SG, Wonderlich JA, et al. Alcohol and other addictive disorders following bariatric surgery: prevalence, risk factors and possible etiologies. Eur Eat Disord Rev. 2015;23:442–50.CrossRefPubMed Steffen KJ, Engel SG, Wonderlich JA, et al. Alcohol and other addictive disorders following bariatric surgery: prevalence, risk factors and possible etiologies. Eur Eat Disord Rev. 2015;23:442–50.CrossRefPubMed
Metadaten
Titel
Surgical Management of Obesity Among People with Schizophrenia and Bipolar Disorder: a Systematic Review of Outcomes and Recommendations for Future Research
verfasst von
Youssef Kouidrat
Ali Amad
Brendon Stubbs
Suzan Moore
Fiona Gaughran
Publikationsdatum
15.05.2017
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 7/2017
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2715-5

Weitere Artikel der Ausgabe 7/2017

Obesity Surgery 7/2017 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.